# Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device Occlusion

> **NCT01958164** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 16 (actual)

## Conditions studied

- Catheter Obstruction
- Vascular Access Devices

## Interventions

- **DRUG:** Actilyse
- **DRUG:** Saline solution
- **DRUG:** Actilyse
- **DRUG:** Actilyse

## Key facts

- **NCT ID:** NCT01958164
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01958164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01958164, "Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device Occlusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01958164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*